Glasshouse Fund
Decision journal

AI fund decision · October 19, 2026

No trades are executed. Maintain core positions, preserve the 28.1% cash reserve, do not average down into AMD or GOOGL, do not add to concentrated AAPL, AMZN, or JNJ exposure, and avoid severely deteriorating speculative and semiconductor watchlist names. Memory-guided constraints favor low turnover and incremental concentration management over reactive trading.

Outlook: NEUTRALPortfolio $1,054,298Cash 28.1%Grounding: ok

Trades

No trades this day. The fund held.

Market calls

A directional call (beat or lag the S&P 500 over the horizon) on every researched name, whether or not the fund traded it. 34 calls (13 outperform, 21 underperform); 0 became trades. These are the fund's calibration record.

beat SPYlag SPYAAPL: outperform at 61%AMD: underperform at 63%AMZN: underperform at 56%APLD: underperform at 76%ASML: underperform at 55%AVGO: underperform at 58%BE: underperform at 68%CAT: underperform at 62%CORZ: underperform at 73%CRWV: underperform at 75%GLW: underperform at 60%GOOGL: underperform at 58%HD: outperform at 54%INTC: underperform at 66%IREN: underperform at 82%JNJ: underperform at 57%JPM: underperform at 53%MA: outperform at 70%META: outperform at 60%MSFT: outperform at 64%MU: underperform at 65%NVDA: outperform at 55%ORCL: underperform at 69%PG: outperform at 69%QQQ: underperform at 56%SNDK: underperform at 71%SPY: outperform at 50%TSLA: underperform at 57%TSM: underperform at 58%UNH: outperform at 62%V: outperform at 69%WMT: outperform at 68%XOM: outperform at 64%^VIX: outperform at 60%50%60%70%80%90%100%
Each tick is one call, placed by stated confidence. Hover for the name.
All 34 calls, with reasoning
SymbolCallConf.Why
IRENUnderperform SPY82%The 22.4% five-day and 37.5% 30-day declines indicate exceptional downside momentum despite favorable commentary.
APLDUnderperform SPY76%Losses of 22.4% over five days and 26.6% over 30 days indicate severe downside momentum.
CRWVUnderperform SPY75%A 23.5% five-day decline and 26.0% 30-day decline outweigh the cited upgrade-driven rebound attempt.
CORZUnderperform SPY73%The stock's 10.3% five-day and 20.5% 30-day declines show persistent high-beta downside momentum.
SNDKUnderperform SPY71%Losses of 12.6% over five days and 16.3% over 30 days dominate the value-oriented rebound thesis.
MAOutperform SPY70%Positive momentum over both five days and 30 days marks MA as a clear relative-strength leader versus SPY.
ORCLUnderperform SPY69%The 6.7% five-day and 11.1% 30-day declines indicate sustained negative relative momentum.
PGOutperform SPY69%Strong positive momentum over both five and 30 days supports defensive outperformance versus SPY.
VOutperform SPY69%Positive five-day and 30-day momentum establishes V as a continuing relative-strength leader.
BEUnderperform SPY68%Double-digit five-day and 30-day declines outweigh speculative earnings-week optimism.
WMTOutperform SPY68%Strong gains over five and 30 days support continued defensive relative leadership.
INTCUnderperform SPY66%Losses of 11.3% over five days and 7.6% over 30 days signal significant relative weakness.
MUUnderperform SPY65%Negative five-day and 30-day returns show continued memory-sector weakness despite rebound commentary.
MSFTOutperform SPY64%Positive 30-day momentum and supportive AI revenue commentary support relative resilience despite a soft recent week.
XOMOutperform SPY64%Positive short- and intermediate-term momentum supports relative outperformance in the current rotation.
AMDUnderperform SPY63%The 11.0% five-day decline and 12.4% loss versus cost indicate fragile near-term semiconductor sentiment despite a positive reported 30-day return.
CATUnderperform SPY62%Negative momentum over both five and 30 days suggests cyclical weakness versus SPY.
UNHOutperform SPY62%Positive momentum over five and 30 days supports relative strength, though rising medical-cost risk remains relevant.
AAPLOutperform SPY61%Positive five-day and 30-day momentum plus reported strong iPhone demand support relative strength versus SPY, though concentration and a bearish analyst view constrain confidence.
GLWUnderperform SPY60%Negative five-day and 30-day performance, together with documented execution and customer-demand risks, imply weaker relative performance.
METAOutperform SPY60%A 6.7% 30-day gain materially exceeds SPY, though the negative five-day return moderates conviction.
^VIXOutperform SPY60%The sharp recent rise in volatility and uneven market breadth support continued elevated volatility versus the equity benchmark.
AVGOUnderperform SPY58%Negative five-day and 30-day returns indicate weakening semiconductor relative strength.
GOOGLUnderperform SPY58%Negative five-day and 30-day momentum and a position below cost offset the longer-term AI opportunity.
TSMUnderperform SPY58%Negative returns over five and 30 days leave TSM exposed to the ongoing semiconductor risk-off rotation.
JNJUnderperform SPY57%Negative five-day and 30-day returns and reported weak medical-device sales point to near-term lagging performance.
TSLAUnderperform SPY57%Negative five-day and 30-day momentum indicate near-term relative weakness.
AMZNUnderperform SPY56%Negative five-day and 30-day momentum point to weaker relative performance despite supportive analyst-catalyst commentary.
QQQUnderperform SPY56%The 4.9% five-day decline and nearly flat 30-day return suggest technology beta may lag a more balanced SPY in the near term.
ASMLUnderperform SPY55%A positive 30-day return is offset by a 6.2% five-day drop amid broad semiconductor de-risking.
NVDAOutperform SPY55%Its positive 30-day return and valuation-supportive news modestly favor SPY outperformance, but the recent 5.4% decline limits confidence.
HDOutperform SPY54%Strong five-day relative strength and nearly flat 30-day performance compare favorably with SPY's 30-day loss.
JPMUnderperform SPY53%Positive five-day momentum is insufficient to offset the negative 30-day trend in a risk-sensitive market.
SPYOutperform SPY50%SPY is the reference benchmark; this neutral baseline call reflects no independent relative-performance assertion.

The debate

Bull, bear and risk cases: bull 0.74 · bear 0.88 · risk 0.97
bull case · conviction 0.74

Buy/hold with emphasis on the portfolio's strongest relative-strength names. The evidence supports selective conviction rather than broad risk-taking: despite the S&P 500 falling 1.36% over 30 days and volatility rising sharply, several holdings delivered positive 30-day momentum, including MA, V, WMT, PG, META, MSFT, UNH, AAPL and NVDA. The strongest combination of momentum, defensive resilience and identifiable catalysts is concentrated in MA, V, WMT, PG, MSFT and AAPL.

  • Relative strength is the clearest bullish signal: MA gained 7.65% over 30 days, V 7.28%, PG 9.05%, WMT 8.92%, META 6.65%, MSFT 4.68%, UNH 4.66% and AAPL 3.12%, all substantially better than the S&P 500's -1.36% 30-day return.
  • MA and V have both positive five-day and 30-day momentum, with MA at +3.75% and +7.65% and V at +3.43% and +7.28%. That combination suggests leadership is continuing rather than merely reflecting a prior bounce.
  • PG, WMT and XOM also show strong defensive/value leadership: PG is +4.01% over five days and +9.05% over 30 days, WMT is +5.07% and +8.92%, and XOM is +3.97% and +8.42%. These names provide portfolio support while volatility is elevated, with the VIX up 31.43% over five days.
  • AAPL has a concrete demand catalyst: reports cite strong demand pushing iPhone Duo deliveries into December, while pre-orders reportedly sold out in minutes. The stock is still advancing, up 0.73% over five days and 3.12% over 30 days, despite broader technology volatility.
  • MSFT is bucking the AI-trade downturn according to the cited news, while analyst views have lifted fair value based on AI revenue expectations. Its +4.68% 30-day momentum supports the idea that investors continue to reward its AI positioning.
  • META combines a strong +6.65% 30-day gain with a large reported holding profit relative to the listed average cost and current price, reinforcing that it remains a successful momentum exposure despite a soft recent five days.
  • UNH has positive five-day and 30-day momentum, at +6.05% and +4.66%, providing evidence of near-term leadership even as medical-cost concerns remain a cited risk.
  • NVDA is not a clean short-term leader, but it remains positive over 30 days at +1.50%, and the news flow includes a potential significant revaluation thesis. Its evidence supports holding rather than aggressively adding after a modest recent pullback.
  • The portfolio has meaningful cash of approximately $296,333, allowing selective purchases of relative-strength leaders without requiring an all-in commitment. The evidence favors adding to or maintaining MA, V, WMT, PG, MSFT and AAPL rather than chasing the weaker momentum names.
  • Risks are visible and should temper conviction: the VIX is rising, GOOGL, JNJ and AMZN have negative 30-day momentum, AMD has fallen 11.02% over five days, and AAPL has a published bearish analyst view. The bullish case is therefore strongest as a selective hold/buy strategy, not an indiscriminate increase in equity exposure.
bear case · conviction 0.88

The bearish case is that portfolio momentum is deteriorating beneath a still-elevated set of holdings, while several candidates show materially worse weakness. The S&P 500 has already declined 1.36% over 30 days, yet multiple current holdings are weakening further: AMD is down 12.4% from cost, GOOGL is down 1.8% from cost and down 2.5% over 30 days, while AMZN, JNJ, JPM, and TSM also show negative 30-day momentum. This creates a risk that the portfolio is exposed to continued rotation and that apparent strength in other positions masks a narrowing or unstable leadership base. Adding candidates with sharply negative momentum would compound that risk rather than improve it.

  • AMD is the clearest existing problem: it is down 12.4% from average cost, substantially worse than the benchmark's 1.36% 30-day decline.
  • GOOGL is both underwater versus cost by 1.8% and losing momentum, with a 30-day decline of 2.5%.
  • AMZN, JNJ, JPM, and TSM all have negative 30-day momentum, indicating weakness is not isolated to one holding or sector.
  • The candidate list contains severe downside momentum: IREN is down 37.5% over 30 days, APLD 26.6%, CRWV 26.0%, CORZ 20.5%, SNDK 16.3%, and BE 13.9%. These are poor entry candidates on the evidence provided.
  • Additional candidates are also weakening, including ORCL at -11.1%, GLW at -8.1%, INTC at -7.6%, CAT at -6.8%, MU at -4.9%, and AVGO at -4.5%, suggesting broad rather than isolated deterioration.
  • The cautionary GLW disclosures identify numerous downside exposures, including customer losses or financing problems, inability to pace capital spending with demand, margin execution risk, technology change, litigation, regulatory developments, and product or component issues.
  • The portfolio has meaningful exposure to securities that have recently appreciated, but the evidence does not establish that those gains are durable; with the benchmark already declining, a further market pullback could expose a larger number of holdings to simultaneous momentum deterioration.
  • AAPL, MSFT, NVDA, UNH, JPM, V, MA, META, PG, WMT, XOM, and TSM lack direct negative return-from-cost evidence in the snapshot, so the bearish case for them is weaker; the strongest evidence is concentrated in AMD, GOOGL, and the deteriorating candidates.
risk case · conviction 0.97

The largest capital risk is concentration: 63.7% of invested assets is held in just AAPL, AMZN, and JNJ, with AAPL alone at 27.1%. This is compounded by a 44.1% Information Technology tilt and an additional 18.4% Consumer Discretionary exposure. Cash is a meaningful 28.1% portfolio buffer, but the invested sleeve remains highly dependent on a small number of holdings and sectors.

  • AAPL is the largest position at 27.1% of invested assets, creating the greatest single-name exposure.
  • AMZN and JNJ add 18.4% and 18.2%, respectively; the top three positions comprise 63.7% of invested assets.
  • Information Technology is the largest sector at 44.1%, led by the sizable AAPL position and supplemented by MSFT, NVDA, TSM, and AMD.
  • Consumer Discretionary represents 18.4%, entirely concentrated in AMZN in the listed positions.
  • Health Care is 20.3%, with JNJ representing 18.2% of invested assets, leaving the sector largely dependent on one holding.
  • The portfolio has 28.1% cash, which reduces total portfolio exposure and provides a liquidity cushion, but does not diversify the invested assets.
  • The evidence does not establish a directional view or specific catalyst; the risk assessment is therefore based on concentration and exposure structure rather than expected price moves.

Cash thesis

Cash at 28.1% is intentionally high because market breadth is uneven, volatility is rising, and the invested sleeve is concentrated in AAPL, AMZN, JNJ, and technology-linked positions. The reserve reduces total-portfolio drawdown sensitivity and avoids forcing purchases into weakening semiconductors or speculative AI-infrastructure names. It will be redeployed only when relative strength broadens or when a high-conviction entry improves portfolio diversification rather than increasing existing concentration.

Full commentary

Bear case response

Accept: AMD is a material weak point relative to cost, down 12.4%, and its 11.0% five-day decline warrants no averaging down; however, its reported 30-day return is still positive at 7.16%, so immediate liquidation is not compelled by the available evidence. Accept: GOOGL is below cost and down 2.5% over 30 days, while AMZN, JNJ, JPM, and TSM also show negative 30-day momentum; these positions should be held without additions and monitored for continued deterioration. Accept: severe negative momentum across IREN, APLD, CRWV, CORZ, SNDK, BE, ORCL, GLW, INTC, CAT, MU, and AVGO argues strongly against new watchlist purchases. Accept: rising volatility and SPY's negative 30-day return reduce confidence in extrapolating recent winners. Reject the implication that broad liquidation is warranted: MA, V, PG, WMT, XOM, MSFT, AAPL, UNH, and META retain meaningful relative strength, and the 28.1% cash allocation already provides substantial defense. The response is therefore to retain cash, hold quality leaders, avoid weak additions, and refrain from overtrading small positions.

Market summary

The market backdrop is mixed and risk-sensitive: SPY is down 1.36% over 30 days while the VIX has risen 31.43% over five days. Large-cap leadership remains selective, with payments, defensives, selected software and several portfolio leaders outperforming, but semiconductor and speculative AI-infrastructure weakness is broad. The appropriate posture is patient, selective, and low turnover.

Portfolio assessment

The portfolio value is $1.054 million with 28.1% cash. Core holdings have generally appreciated, but concentration remains the primary issue: AAPL, AMZN, and JNJ are very large exposures, while technology-linked holdings remain correlated. Current evidence supports holding relative-strength leaders rather than adding to them, avoiding purchases in weak momentum names, and preserving flexibility rather than making a broad directional allocation change.

Risk assessment

The central risks are single-name and sector concentration, not inadequate market exposure. AAPL is approximately 19.5% of total portfolio value, while AAPL, AMZN, and JNJ together dominate the equity sleeve. Technology exposure is vulnerable to a continued AI and semiconductor de-risking cycle, affecting MSFT, NVDA, TSM, AMD, GOOGL, and indirectly AMZN. AMD, GOOGL, AMZN, JNJ, JPM, and TSM have negative short-term or 30-day signals, while large unrealized gains in AAPL, MSFT, META, V, and MA could be vulnerable if volatility continues to rise. Fund memory requires incremental risk management and avoidance of repeated turnover or renewed concentration.

← October 16, 2026 October 20, 2026 →